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RESEARCH ARTICLE Open Access
Effects of exercise on depression in adults
with arthritis: a systematic review with
meta-analysis of randomized controlled trials
George A Kelley1*, Kristi S Kelley1 and Jennifer M Hootman2
Abstract
Introduction: Previous randomized controlled trials have led to conflicting findings regarding the effects of
exercise on depressive symptoms in adults with arthritis and other rheumatic conditions (AORC). The purpose of
this study was to use the meta-analytic approach to resolve these discrepancies.
Methods: The inclusion criteria were: (1) randomized controlled trials, (2) exercise (aerobic, strength training, or
both) ≥4 weeks, (3) comparative control group, (4) adults with osteoarthritis, rheumatoid arthritis, fibromyalgia or
systemic lupus erythematosus, (5) published studies in any language since January 1, 1981 and (6) depressive
symptoms assessed. Studies were located by searching 10 electronic databases, cross-referencing, hand searching and
expert review. Dual-selection of studies and data abstraction was performed. Hedge’s standardized mean difference
effect size (g) was calculated for each result and pooled using random-effects models, an approach that accounts for
heterogeneity. Non-overlapping 95% confidence intervals (CI) were considered statistically significant. Heterogeneity
based on fixed-effect models was estimated using Q and I2 with alpha values ≤0.10 for Q considered statistically
significant.
Results: Of the 500 citations reviewed, 2,449 participants (1,470 exercise, 979 control) nested within 29 studies were
included. Length of training, reported as mean ± standard deviation (±SD) was 19 ± 16 weeks, frequency 4 ± 2 times
per week and duration 34 ± 17 minutes per session. Overall, statistically significant exercise minus control group
reductions were found for depressive symptoms (g = −0.42, 95% CI, −0.58, −0.26, Q = 126.9, P <0.0001, I2 = 73.2%). The
number needed-to-treat was 7 (95% CI, 6 to 11) with an estimated 3.1 million (95% CI, 2.0 to 3.7) United States adults not
currently meeting physical activity guidelines improving their depressive symptoms if they began and maintained a
regular exercise program. Using Cohen’s U3 Index, the percentile reduction was 16.4% (95% CI, 10.4% to 21.9%). All studies
were considered to be at high risk of bias with respect to blinding of participants and personnel to group assignment.
Conclusions: Exercise is associated with reductions in depressive symptoms among selected adults with AORC. A need
exists for additional, well-designed and reported studies on this topic.
Introduction
Arthritis is a major public health problem among adults
in the United States (US). Current US estimates place
the prevalence of doctor-diagnosed arthritis at 55.2 mil-
lion (22.7%) adults [1], and is projected to increase to 67
million (25%) adults by the year 2030 [2]. Not surpris-
ingly, the costs associated with arthritis and other
rheumatic conditions are substantial. In 2003, the total
costs associated with arthritis were estimated at $127.8
billion, $80.8 billion in direct costs and $47.0 billion in
indirect costs [3]. A common mental health problem
among adults with arthritis is depression. For example, a
recent study of 1,793 US adults 45 years of age and older
with arthritis found that 18% had depression while only
51% sought help for their depression [4]. One potential
non-pharmacologic intervention for reducing depressive
symptoms in adults with arthritis is exercise. Unfortunately,
the prevalence of exercise in adults with arthritis is low. For
example, the percentage of adults with doctor-diagnosed
arthritis who perform moderate physical activity for at least
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30 minutes per day, three days per week, has been re-
ported to be only 37% [5]. In addition, previous ran-
domized controlled trials that examined the effects of
exercise (aerobic, strength training, or both) on de-
pressive symptoms in adults with arthritis and other
rheumatic conditions (AORC) have led to conflicting
results [6-34] with 23 and 36 exercise versus control
between-group differences reported as either statisti-
cally significant [12-14,18,19,21,23,25,27-30,32,33] or
null [6-11,15-18,20,22-24,26,31,34], respectively. While
this may lead one to generally conclude that exercise
does little to reduce depressive symptoms in adults
with AORC, this would be shortsighted since it relies
on the vote-counting approach [35], an approach that
has been shown to be less valid than the meta-analytic
approach [35]. Recently, two members of the investiga-
tive team (GAK and KSK) conducted a systematic re-
view of previous meta-analyses addressing the effects
of exercise on depressive symptoms in adults with
AORC [36]. Only two previous meta-analyses, limited
to adults with fibromyalgia [37,38], met the criteria for in-
clusion [36]. Exercise minus control group reductions in
depressive symptoms were found for both meta-analyses
(standardized mean difference (SMD), −0.61, 95% confi-
dence interval (CI), −0.99 to −0.23, P = 0.002; SMD, −0.32,
95% CI, −0.53 to −0.12, P = 0.002 [36]. Another meta-
analysis that included participants with a variety of chronic
illnesses and which was excluded from our previous review
[36] found a SMD reduction of −0.29 (95% CI, −0.16
to −0.43) in depressive symptoms among fibromyalgia
participants as well as a reduction of −0.23 (95% CI, −0.11
to −0.34) in participants with chronic pain other than
fibromyalgia [39]. However, these latter findings included
participants with conditions other than arthritis, for
example back pain. In addition, while this previous
meta-analysis included an analysis for such things as
small-study effects, number-needed-to treat and meta-
regression, these analyses were conducted across all
chronic illnesses versus those with AORC [39]. While
these previous findings are encouraging, no meta-
analysis focused specifically on the effects of exercise on
depressive symptoms in adults with other AORC
(osteoarthritis, rheumatoid arthritis, systemic lupus ery-
thematous), met the eligibility criteria. Since the effects
of exercise on depressive symptoms may vary across dif-
ferent AORC, the inclusion of such populations in a
meta-analysis is important. In addition, the most recent
meta-analysis of the two [38] was limited to studies
published up until April 2009, suggesting the need for a
more up-to-date review on the topic. Thus, the purpose
of the current study was to conduct a systematic review
with meta-analysis to determine the effects of exercise
(aerobic, strength training, or both) on depressive
symptoms in adults with AORC.
Methods
Study eligibility criteria
The a priori inclusion criteria for this meta-analysis were
as follows: (1) randomized controlled trials with the unit of
assignment at the participant level, (2) exercise-only inter-
vention group (aerobic, strength training, or both), (3)
community-deliverable exercise interventions ≥4 weeks in
duration, (4) comparative control group (non-intervention,
usual care, wait-list control, attention control), (5) adults
18-years old and older with one of the following: rheuma-
toid arthritis, osteoarthritis, or fibromyalgia, (6) studies
published in any language between 1 January 1981 and 1
January 2013, (7) depressive symptoms as an outcome. Post
hoc, a decision was made to include studies in adults with
systemic lupus erythematosus. For this proposed project,
community-deliverable exercise interventions were defined
as those that could be performed, or had the potential to
be adapted and performed, by persons in a community set-
ting (recreation or senior centers, in the home or neighbor-
hood, etc.) and meet the implementation guidelines for
physical activity interventions recommended by the
Arthritis Program at the Centers for Disease Control and
Prevention [40]. This includes exercise in a pool [40]. An
exercise duration of at least four weeks was chosen based
on previous meta-analytic research that included physical
activity regimens of as little as four weeks and in which de-
pressive symptoms were reduced in the general adult
population [41]. Studies were limited to full articles pub-
lished in peer-reviewed journals and examined for potential
publication bias based on recent recommendations (see
Statistical Analysis section for description) [42]. Unpub-
lished work, defined as master’s theses, dissertations, ab-
stracts from conference proceedings, technical reports and
studies filed in an investigator’s drawer, was not included.
The rationale for this decision was based on the work of
van Driel et al. [43], who concluded that: (1) the difficulty
in retrieving unpublished work could lead to selection bias,
(2) many unpublished trials are eventually published, (3)
the methodological quality of such studies is poorer than
those that are published, and (4) the effort and resources
required to obtain unpublished work may not be warranted
[43]. This approach is consistent with recent practice [43].
The year 1981 was chosen as the starting point for study
searches based on a preliminary search in PubMed in
which the first cited randomized controlled trial on exer-
cise and arthritis in adults was published in 1981 [44].
Data sources
Studies were retrieved using the following 10 electronic
databases: (1) Medline, (2) CINAHL, (3) Sport Discus, (4)
PsycINFO, (5) Scopus, (6) Academic Search Complete, (7)
Proquest, (8) Cochrane Central Register of Controlled Tri-
als, (9) PEDro and (10) Web of Science. All electronic
searches were conducted by a Health Sciences librarian
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(JS) with assistance from the first and second authors.
While the search strategies used varied according to the
requirements of the different databases searched, key-
words centered on the terms ‘exercise’, ‘arthritis’ and ‘de-
pression’. An example of the search strategy for one
database (Scopus) can be found in Additional file 1. After
removing duplicates and completing the study selection
process, the overall precision of the searches was calcu-
lated by dividing the number of studies included by the
total number of studies screened [45]. The number needed
to read (NNR) was then calculated as the inverse of the
precision [45]. In addition to electronic database searches,
cross-referencing for potentially eligible meta-analyses
from retrieved reviews was also conducted as well as ex-
pert review. All studies were stored in Reference Manager,
version 12.0.1 [46].
Study selection
All studies were selected by the first two authors, inde-
pendent of each other. Disagreements regarding the final
list of studies to be included were resolved by consensus.
Multiple publication bias was addressed by only includ-
ing one set of data on the same subjects. All included
studies, as well as a list of excluded studies, including
reasons for exclusion, were stored in Reference Manager
(version 12.0.1) [46].
Data abstraction
Prior to data abstraction, a detailed codebook that could
hold up to 260 items per study was developed by all
three members of the research team in Microsoft Excel
2007 [47]. The major categories of variables that were
coded included: (1) study characteristics, (2) subject
characteristics, (3) exercise program characteristics, (4)
primary outcomes and (5) secondary outcomes. The pri-
mary outcome for this study, established a priori, was
changes in depressive symptoms. Secondary outcomes
included the following variables: body weight, body mass
index (BMI) in kg.m2, percent body fat, physical func-
tion, pain (global), quality of life (overall score), anxiety,
aerobic fitness (VO2max in ml
.kg-1.min−1), muscular
strength (upper and lower body) and balance (overall,
dynamic or static). Secondary outcomes were only in-
cluded if data for depressive symptoms were available.
Our rationale for including these secondary outcomes
was based on their potential impact on depressive
symptoms as well as the fact that they are often at less
than optimal levels in adults with AORC. All studies
were coded by the first two authors, independent of
each other. They then met and reviewed every entry
(22,136 total) for accuracy and consistency. Discrepan-
cies were resolved by consensus. If consensus could not be
reached, the third author served as an arbitrator. Using
Cohen’s kappa statistic [48], the overall agreement rate
prior to correcting discrepant items ranged from 0.70 to
0.98 x  SD ¼ 0:89 0:07; Mdn ¼ 0:90ð Þ.
Risk of bias
The Cochrane Collaboration risk of bias instrument was
used to assess bias across six domains: (1) random se-
quence generation, (2) allocation concealment, (3) blind-
ing of participants and personnel, (4) blinding of outcome
assessment, (5) incomplete outcome data, (6) selective
reporting and (7) whether the participants were physically
inactive, as defined by the original study authors, prior to
taking part in the study [49]. Each item was classified as
having a high, low, or unclear risk of bias [49]. Assessment
for risk of bias was limited to the primary outcome of
interest, changes in depressive symptoms. Since it is im-
possible to blind participants to group assignment in exer-
cise intervention protocols, all studies were considered to
be at a high risk of bias with respect to blinding of partici-
pants and personnel. Based on previous research, no study
was excluded based on the results of the risk of bias as-
sessment [50]. All assessments were performed by the first
two authors, independent of each other. Both authors then
met and reviewed every item (203 total) for agreement.
Disagreements were resolved by consensus. Using Cohen’s
kappa statistic [48], the overall agreement rate prior to
correcting discrepant items ranged from 0.14 to 0.71
x  SD ¼ 0:63 0:32; Mdn ¼ 0:71ð Þ.
Statistical analysis
The a priori plan was to conduct a one-step individual
participant data (IPD) meta-analysis [51]. However, be-
cause of: (1) the inability to obtain IPD from all eligible
studies, (2) the inability to resolve discrepancies between
the IPD provided and data reported in the published
studies, for example, final sample sizes and (3) the po-
tential loss of power with fewer included studies at the
IPD level, a post hoc decision was made to conduct an
aggregate data meta-analysis, an approach similar to
conducting a two-step meta-analysis with IPD [51].
Calculation of effect sizes for primary and secondary
outcomes from each study
The primary outcome for this study was depressive
symptoms, calculated as the SMD effect size g. This was
accomplished by subtracting the change score difference
in the exercise group from the change score difference
in the control group. Variances were calculated from the
pooled standard deviations of change scores in the inter-
vention and control groups. If change score standard de-
viations were not available, these were calculated from
reported 95% CIs, pre and post standard deviation (SD)
values according to procedures developed by Follmann
et al. [52], or other traditional methods (for example, t-
tests, exact probability values). Each g was then weighted
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by the inverse of its variance and adjusted for small sam-
ple bias [53]. The beneficial effects of exercise on de-
pressive symptoms were denoted by a negative g. Studies
that used assessment instruments in which a positive g
represented reductions in depressive symptoms were re-
verse scaled so that negative values were indicative of
improvements. In order to try to maintain independence
as well as the fact that no one most valid and reliable
measure for assessing depressive symptoms in adults
with AORC exists, overall results were pooled for those
studies that assessed depressive symptoms using more
than one assessment instrument. The same approach
was used for studies that reported results based on both
intention-to-treat and per-protocol analyses. Effect sizes
for secondary outcomes were calculated using either the
original metric, for example body weight in kilograms,
or g given the different assessment instruments used for
many of the included outcomes (anxiety, pain, and etc.).
For all secondary outcomes the beneficial direction
of effect reported was the natural direction of benefit,
for example, negative values for decreases in anxiety,
positive values for increases in quality-of-life. Where ne-
cessary, values were reverse-scaled. Similar to depressive
symptoms, results were pooled for those studies that
assessed any secondary outcomes using more than one
assessment instrument and/or analyzed data using both
the intention-to-treat and per-protocol approach.
Pooled estimates for primary and secondary outcomes
Random-effects, method-of-moments models that in-
corporate heterogeneity into the overall estimate were
used to pool both primary and secondary outcomes from
each study [54]. Multiple groups from the same study,
for example aerobic and strength training groups, were
analyzed independently as well as collapsing multiple
groups so that only one result represented each outcome
from each study. The rationale for collapsing multiple
groups so that only one effect size represented each out-
come from each study was based on the tendency for re-
sults from multiple groups in the same study to be
correlated, the result being a loss of statistical independ-
ence. This study-level analysis was limited to overall find-
ings only. All other analyses (influence analysis, cumulative
meta-analysis, moderator analysis, simple meta-regression,
etc.) were conducted with group level data. While
results were pooled for those studies in which the same
outcome was measured using more than one assessment
instrument and/or results were reported using both
intention-to-treat and per-protocol approaches, separate
moderator analyses were also conducted for each assess-
ment type and type of analysis. Non-overlapping 95% CI
were considered statistically significant. To enhance prac-
tical application, the number-needed-to treat (NNT) was
calculated for any overall findings that were reported as
statistically significant. This was accomplished using the
approach suggested by the Cochrane Collaboration and as-
suming a control group risk of 30% [55]. Briefly, based on
recommendations of the Cochrane Collaboration [55], we
converted the standardized mean difference into a natural
log odds ratio, odds ratio, assumed control risk, based on
30%, and finally, the NNT. The 30% control group risk was
based on a previous review by Sonawalla and Rosenbaum
[56] in which it was reported that mean placebo response
rates in antidepressant clinical trials were 30% to 40%.
Based on the NNT for changes in depressive symptoms,
gross estimates of the number of adults with AORC in the
US who could benefit from exercise but were not meeting
current exercise guidelines were calculated. This was based
on an estimated 34.8 million US adults with doctor-
diagnosed arthritis, derived by multiplying the number of
adults with doctor-diagnosed arthritis (55.2 million) [1] by
the percentage of adults with arthritis who were not cur-
rently meeting physical activity guidelines (63%) [5]. Prac-
tical application was further enhanced by calculating
Cohen’s U3 index, an index used to determine the percent-
ile gain in an intervention group [57]. For example, a g of
0.40 suggests that, on average, a person in the exercise
group would be at approximately the 66th percentile in
terms of improving their depressive symptoms. This trans-
lates into being approximately 16 percentiles higher than
the control group [58].
Stability and validity of changes in primary and secondary
outcomes
Heterogeneity of results between studies was examined
using Q as well as an extension of the Q statistic, I2
[59]. Statistical significance for Q was set at an alpha
value of ≤0.10. For I2, values of <25%, 25% to <50%, 50%
to <75% and 75% or greater were considered to repre-
sent very low, low, moderate and large amounts of in-
consistency, respectively [59]. To determine treatment
effects in a new trial, 95% prediction intervals (PI) were
also calculated [60,61]. Small-study effects (publication
bias, and so on) were examined qualitatively and quanti-
tatively based on recent recommendations [42]. This in-
cluded funnel plots as well as the regression approach
of Egger et al. [42,62]. Non-overlapping 95% CIs for
Egger’s regression test for the intercept (β0) were con-
sidered to be indicative of small-study effects. Outliers
were considered to be individual study results in which
their 95% CI did not overlap with the 95% CI from pooled
results. In order to examine the effects of each result from
each study on the overall findings, results were analyzed
with each study deleted from the model once. Cumulative
meta-analysis, ranked by year, was used to examine the ac-
cumulation of evidence over time [63]. Cumulative meta-
analysis is an approach where studies are added one at a
time and the results summarized as each new study is
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added. This allows one to visually examine how results
have accumulated, and possibly changed, over time [63].
Moderator analysis for depressive symptoms
Within and between-group differences in depressive
symptoms for categorical variables were examined using
mixed effects models that consisted of a random-effects
model for combining studies within each subgroup and
a fixed effect-model across subgroups [64]. Between-
study variance (tau-squared) was considered to be un-
equal for all subgroups. This value was computed within
subgroups but not pooled across subgroups. Categorical
analyses included: (1) study characteristics (country, type
of control group, whether IPD was provided, random se-
quence generation, allocation concealment, blinding of
participants and personnel, blinding of outcome assessor,
incomplete data, selective outcome reporting, whether
subjects were physically inactive prior to enrollment as
defined by the original study authors, type of analysis
performed, provision of sample-size estimates, whether
the study was funded, method to assess depression), (2)
participant characteristics (adverse events, sex, race/eth-
nicity, cigarette smoking, whether participants were
overweight and/or obese (BMI ≥25 kg/m2), type of
AORC, medications taken for AORC) and (3) exercise
intervention characteristics (type, intensity, delivery). In-
tensity for aerobic exercise was categorized as low (<40%
of heart rate/VO2 reserve or <55% of maximal heart
rate), moderate (between 40% and 59% of heart rate/
VO2 reserve or 55% and 69% of maximal heart rate) or
high (>59% of heart rate/VO2 reserve or >69% of max-
imal heart rate) [65]. Intensity for strengthening exercise
was categorized as low (<50% of 1-repetition maximum),
moderate (between 50% and 69% of 1-repetition max-
imum) or high (>69% of 1-repetition maximum for
strength exercise) [65]. Post hoc, type of exercise was
also examined by separating out tai chi and qi gong from
combined aerobic and strength training. The rationale
for this was based on the fact that both tai chi and qi
gong are considered to be meditative movement therap-
ies which include a mental component that is not trad-
itionally included in typical aerobic and strength training
interventions. Non-overlapping 95% CI for both within
and between-group analyses were considered statistically
significant. All moderator analyses were considered
exploratory [66].
Meta-regression for changes in depressive symptoms and
potential covariates
Simple mixed-effects, method of moments meta-regression
was used to examine the potential association between
changes in depressive symptoms and continuous variables
[64]. Because missing data for different variables from dif-
ferent studies was expected, only simple meta-regression
was planned and performed. Potential predictor variables
included: (1) study characteristics (year of publication, per-
centage of dropouts), (2) participant characteristics (age,
symptom duration, diagnosis duration, changes in body
weight, BMI in kg.m2, percent body fat, physical function,
pain, quality of life, anxiety, maximum oxygen consump-
tion, expressed as VO2max in ml
.kg-1.min−1, upper and lower
body strength, balance) and (3) exercise intervention char-
acteristics (length, frequency, duration of training, compli-
ance, total minutes per week, calculated as frequency x
duration, total minutes per week, adjusted for percent com-
pliance, total minutes of training for the entire intervention
period, calculated as length x frequency x duration, and
total minutes of training, adjusted for compliance). Non-
overlapping 95% CI for the slope (β1) were considered sta-
tistically significant. Because this was a meta-analysis, all
meta-regression analyses were considered exploratory [66].
Software used for statistical analysis
Analyses were carried out using Comprehensive Meta-
Analysis (version 2.2) [67], Microsoft Excel 2010 [68],
and two external add-ins for Excel, SSC-Stat (version
2.18) [69] and EZ-Analyze (version 3.0) [70].
Reporting metrics
Selected data are reported as mean ± standard deviation
x  SDð Þ and median (Mdn).
Results
Study characteristics
A general description of the characteristics of each study
is shown in Table 1. Of the 500 citations reviewed, a
total of 2,449 participants (1,470 exercise, 979 control)
nested within 64 groups (35 exercise, 29 control) and 29
studies were included in the final analysis [6-34]. The pre-
cision of the searches was 0.06 while the NNR was 17. A
description of the search process, including the reasons
for excluded studies, is shown in Figure 1 while a list of
each excluded study, including the reason(s) for exclusion,
is shown in Additional file 2. The number of exercise
groups exceeded the number of studies because six studies
included more than one group [11,19,20,23,24,26]. The
number of subjects in each group from each study varied
widely, ranging from 8 to 149 in the exercise groups
x  SD ¼ 42 35; Mdn ¼ 28ð Þ and 8 to 144 in the con-
trol groups x  SD ¼ 34 30; Mdn ¼ 27ð Þ. Twenty-eight
studies were published in English language journals
[6-27,29-34] and one in Spanish [28]. Studies were con-
ducted in eleven different countries; thirteen in the United
States [7-10,16,17,19,20,22-24,32,33], two each in either
Brazil [15,30], Canada [12,26], Finland [14,31], Portugal
[28,29], Spain [6,25] or Sweden [13,18], and one each in
either Australia [11], Norway [34], Turkey [27], or the
United Kingdom [21]. For types of controls, eight
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Table 1 General characteristics of studies
Study Country Participants Exercise intervention Depression assessment
Alentorn-Geli et al. [6] Spain 24 women with FM randomly assigned to either an exercise
(n = 12, x ± SD = 53.7 ± 9.4 yrs) or control group
(n = 12, age, x ± SD = 59.3 ± 7.3 yrs)
2 x/wk, 90 min/d (aerobic, 30 min walking, 65-85%
MHR, or salsa dancing: 2, 15/min sessions plus
stretching and relaxation exercises) for 6 wks
FIQ (depression)
Buckelew et al. [7] United States 60 men and women with FM assigned to either an exercise
(n = 30, age x ± SD = 45.6 ± 9.4 yrs) or attention control
group (n = 30, age, x ± SD = 44.3 ± 11.2 yrs)
1-3 x/wk, 1.5-3 hr/session, ROM exercises, strengthening
exercises, and low-moderate intensity aerobic exercise
(walking at 60-70% MHR) for 6 wks
CES-D
Daltroy et al. [8] United States 71 men and women with either RA or SLE assigned to either an
exercise (n = 35, age x ± SD = 38.4 ± 7.5 yrs, range 18–50 yrs) or
an attention control group (n = 36, age, x ± SD = 35.7 ± 7.1 yrs,
range 18–50 yrs)
2.2 x/wk, 30 min/session, home-based, unsupervised
aerobic exercise (walk, jog, cycle, swim) at
60-80% MHR for 24 wks
CES-D
Etnier et al., [9] United States 16 women (age x ± SD = 55.1 ± 8.9 yrs, range 32–70 yrs)
with FM assigned to an exercise (n = 8) or wait-list
control group (n = 8)
3 d/wk, 60 min/session: walk, 15 min, 55-65% MHR,
8-station light resistance exercise circuit, static-bridging
exercises, stretching, for 18 wks
CES-D
Fontaine et al., [10] United States 84 men and women with FM assigned to a lifestyle physical
activity (n = 46, age, x ± SD = 46.4 ± 11.6 yrs) or control
group (n = 38, age, x ± SD = 49 ± 10.2 yrs)
5-7 d/wk, accumulate 30 min of moderate-intensity physical
activity in short bouts throughout the day by walking,
garden/outdoor, household or sports activity for 12 wks
CES-D
Fransen et al., [11] Australia 152 men and women with OA of the hip or knee assigned
to a hydrotherapy (n = 55, age, x ± SD = 70 ± 6.3 yrs),
tai chi (n = 56, x ± SD = 70.8 ± 6.3 yrs), or control group
(n = 41, age, x ± SD = 69.6 ± 6.1 yrs)
2 x/wk, 1 hr/session, of either Tai Chi (for Arthritis,
24 modified forms of Sun style) or hydrotherapy
exercises in warm water, for 12 wks
DASS-21
Gowans et al., [12] Canada 57 men and women with FM assigned to an exercise (n = 30,
age, x ± SD = 44.6 ± 8.7 yrs), or control group
(n = 27, age, x ± SD = 49.8 ± 7.3 yrs)
3 d/wk, 30 min/session, aerobic exercise (2 walking/jogging
classes in a gym, 1 pool class) at 60-75%MHR, for 23 wks
BDI, MHI (depression)
Haak and Scott, [13] Sweden 57 women with FM assigned to an intervention
(n = 29, x ± SD = 54 ± 9.4 yrs of age) or wait-list control
group (n = 28, x ± SD = 53.4 ± 8 yrs of age)
qigong, 9 group sessions over 7 weeks (11.5 hours total),
2 × per day at home for 20 minutes each
BDI
Hakkinen et al., [14] Finland 21 premenopausal women with FM assigned to a progressive
strength training (n = 11, x ± SD = 39 ± 6 yrs) or control
group (n = 10, x ± SD = 37 ± 5 yrs)
2 days/wk of supervised progressive strength training,
6–8 exercises, 8–20 reps, 40-80% 1RM, for 21 weeks
BDI
Ide et al., [15] Brazil 40 women with FM assigned to either an exercise
(n = 20, age, x ± SD = 46.6 ± 9.8 yrs) or control group
(n = 20, age, x ± SD = 45.5 ± 8.65 yrs)
4 d/wk, 1 hr/session, aquatic respiratory exercise-based
program in warm water, for 4 wks
FIQ (depression)
Jones et al., [16] United States 101 men and women with FM assigned to a placebo
and exercise (n = 47, x ± SD = 49.6 ± 7.7 yrs of age)
or attention control: placebo plus diet recall group
(n = 54, x ± SD = 49.8 ± 7.9 yrs of age)
3 x/wk, 60 min/session, low-impact, nonrepetitive
cardioaerobics (30 min), strength training (10 min),
flexibility training (5 min), balance training (5 min),
and relaxation (10 min) at 40-50% MHR or Borg RPE
scale 10–12, for 6 months
FIQ (depression)
Komatireddy et al., [17] United States 49 men and women with RA assigned to a circuit training
(n = 25, x ± SD = 57.7 ± 9.8 yrs of age, range 40–72 yrs) or
control group (n = 24, x ± SD = 60.5 ± 11 yrs of age,
range 35–76 yrs)
Circuit weight bearing with light loads and high
repetitions, 7 exercises, 2–3 circuits/session, 12–15
reps,30-second rest between sets, 20–27 min/session,
at least 3 x/wk, RPE of 3–4, for 12 wks
AIMS (depression)
Mannerkorpi et al., [18] Sweden 69 women with FM assigned to either a training
(n = 37, x ± SD = 45 ± 8 yrs of age) or control group
(n = 32, x ± SD = 47 ± 11.6 yrs of age)
1 d/wk, 35 min/session, endurance, flexibility, coordination
and relaxation exercises in a temperate pool for 6 months
FIQ (depression),
AIMS (depression)
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Table 1 General characteristics of studies (Continued)
Minor et al., [19] United States 115 men and women ages 21–83 yrs with RA
or OA assigned to a pool (n = 47), walking
(n = 36) or control group (n = 32)
3 x/wk, 1 hr/session (30 min of this was aerobic),
60-80% MHR, for 12 wks either in a pool (aerobic
aquatics) or walk (aerobic walking) group
AIMS (depression)
Neuberger et al., [20] United States 310 men and women age 55.5, range 40–70 yrs,
with RA assigned to a class (n = 102), or
home-based (videotape) exercise (n = 103),
or control group (n = 105)
3 d/wk, 1 hr/session, low-impact aerobics (25.4 min,
range 10–30 min/session) and strength training
(16.67 min, range 15–20 min/session), 60-80%
MHR, for 12 wks
CES-D, POMS
O’Reilly et al., [21] United Kingdom 191 men and women with knee OA ages 40–80 yrs
assigned to an exercise (n = 113, x ± SD = 61.9 ± 10.0
yrs of age) or control group (n = 78, x ± SD = 62.2 ± 9.7
yrs of age)
5 strengthening exercises, 20 reps per leg, performed
at home on a daily basis for 6 months
HAD
Patrick et al., [22] United States 249 men and women 55–75 yrs of age with OA
assigned to either an exercise (n = 125, 65.7 yrs of
age) or wait-list control group (n = 124, 66.1 yrs of age)
2-7 d/wk, 45–60 min/session of aquatic exercise, for 20 wks CES-D
Penninx et al., [23] United States 439 men and women (x ± SD = 68.8 ± 5.6 yrs of age)
assigned to an aerobic (n = 149), resistance, (n = 146)
or control group (n = 144)
78 wks of training; Aerobic group: 3 d/wk, 40 min/session,
50-70%HRR, walking; Resistance group: 3 d/wk, 40 min/session,
2 sets, 10 reps using dumbbells and cuff weights
CES-D
Rooks et al., [24] United States 152 women with FM assigned to an aerobic and
flexibility (n = 51, x ± SD = 48 ± 11 yrs of age),
strength training, aerobic, and flexibility
(n = 51, x ± SD = 50 ± 11 yrs of age) or control
group (n = 50, x ± SD = 51 ± 12 yrs of age)
3 d/wk, of either aerobic (45 min walking) and flexibility
exercises or aerobic (20 min walking), strength training
(25 min, 6 exercises, 50% 1RM, 1–2 sets of 6–12 reps),
and flexibility exercises for 16 wks
FIQ (depression), BDI
Sanudo et al., [25] Spain 42 women with FM assigned to an exercise
(n = 21, x ± SD = 55.5 ± 7.1 yrs of age) or control
group (n = 21, x ± SD = 56.2 ± 8.5 yrs of age)
2 x/wk, aerobic (walk/jog, 10–15 min, 65-70% MHR),
strength training (15–20 min, circuit of 8 exercises,
1 set, 8–10 reps), and flexibility exercises (10 min,
8–9 stations, 1 set, 3 reps for 30 sec), for 24 wks
BDI
Schachter et al., [26] Canada 143 women with FM (20–55 yrs of age) assigned to a
short bout (n = 56, x ± SD = 41.9 ± 8.6 yrs of age),
long bout (n = 51, x ± SD = 41.3 ± 8.7 yrs of age),
or control group (n = 36, x ± SD = 42.5 ± 6.7 yrs
of age)
Home-based, videotape-based, low impact aerobic
exercise to music. Short bout group: 2 x/d, 7.1 x/wk,
12.3 min/session, 60% HRR; Long-bout group: 1 x/d,
3.6 x/wk, 25.5 min/session, 60% HRR, for 16 wks
FIQ (depression)
Sencan et al. [27] Turkey 40 women with FM assigned to an aerobic exercise
(n = 20, x ± SD = 35.4 ± 9.6 yrs of age) or control
TENS treatment group (n = 20, x ± SD = 35.55 ±
7.9 yrs of age)
3 x/wk, 40 min/session, aerobic exercise (cycle ergometer
for 30 min, plus 5 min warm-up and 5 min cool-down)
for 6 wks
BDI
Tomas-Carus et al. [28] Portugal 34 women with FM assigned to aquatic exercise
(n = 17, x ± SD = 51 ± 10 yrs of age) or control
group (n = 17, x ± SD = 51 ± 9 yrs of age)
3 x/wk, pool exercises performed in warm water, 20 min
aerobic, 60-65% MHR, 20 min strength exercises, 4 sets,
10 reps, for 12 wks
FIQ (depression)
Tomas-Carus et al. [29] Portugal 33 women with FM assigned to aquatic exercise
(n = 17, x ± SD = 50.7 ± 10.6 yrs of age) or control
group (n = 16, x ± SD = 50.9 ± 6.7 yrs of age)
3 x/wk, pool exercises performed in warm water, 20 min
aerobic, 60-65% MHR, 20 min strength exercises, 4 sets,
10 reps, for 8 months
FIQ (depression)
Valim et al. [30] Brazil 76 women with FM assigned to an exercise
(n = 38, x ± SD = 47 ± 10 yrs of age) or stretching
group (n = 38, x ± SD = 44 ± 11 yrs of age)
3 x/wk, 45 min/session, aerobic exercise group walked,
for 20 wks. Stretching (control) group 3 x/wk, 45
min/session, 17 exercises for flexibility but without
raising HR, for 20 wks
BDI
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Table 1 General characteristics of studies (Continued)
Valkeinen et al. [31] Finland 26 women with FM assigned to a strength training
(n = 13, x ± SD = 60.2 ± 2.5 yrs of age, range 57–64 yrs)
or control group (n = 13, x ± SD = 59.1 ± 3.5 yrs of age,
range 54–65 yrs)
2 x/wk, 60–90 min/session, strength training, 7–8
exercises, 3–5 sets, 5–20 reps, 40-70% 1 RM, for
21 wks
BDI
Wang et al. [32] United States 40 men and women with knee OA assigned to a Tai Chi
(n = 20, x ± SD = 63 ± 8.1 yrs of age) or attention control
group (n = 20, x ± SD = 68 ± 7 yrs of age)
2 d of supervised Tai Chi for 30 min; Tai Chi every
day at home for at least 20 min; 10 forms of
classic Yang style Tai Chi, for 12 wks
CES-D
Wang et al. [33] United States 66 men and women with FM assigned to a Tai Chi
(n = 33, x ± SD = 49.7 ± 11.8 yrs of age) or attention
control group (n = 33, x ± SD = 50.5 ± 10.5 yrs of age)
2 d of supervised Tai Chi (Yang Style-10 forms)
for 60 min; Tai Chi every day at home for at
least 20 min, for 12 wks
CES-D
Wigers et al. [34] Norway 40 men and women with FM assigned to an aerobic
exercise (n = 20, x ± SD = 43 ± 9 yrs of age, range 23–62 yrs)
or treatment-as-usual group (n = 20, x ± SD = 46 ± 9 yrs
of age, range 29–73 yrs)
3 x/wk, 18–20 min/session of aerobic exercise with
1) music session, 2) aerobic games (tag, ball games)
at 60-70% MHR, for 14 wks
VAS
Description of groups limited to those that met the inclusion criteria for the current meta-analysis. Number of subjects based on initial versus final number of subjects included in the studies. AIMS, Arthritis Impact
and Measurement Scale for depression; BDI, Beck Depression Inventory; CES-D, Center for Epidemiologic Studies Depression Scale; d, day(s); DASS, Depression, Anxiety and Stress Scale; FIQ, Fibromyalgia Impact Scale
for depression; FM, fibromyalgia; h, hour(s); HAD, Hospital Anxiety and Depression Scale; HR, heart rate; HRR, heart rate reserve; MHI, Mental Health Inventory; MHR, maximum heart rate; min, minute(s); OA, osteoarthritis; POMS,
Profile of Moods States; RA, rheumatoid arthritis; reps, repetitions; RM, repetition maximum; ROM, range of motion; RPE, rate of perceived exertion; sec, second(s); SLE, systemic lupus erythematosus; VAS, Visual Analog Scale;
wk, week(s); x, times; x ± SD; mean ± standard deviation; yr, year(s).
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appeared to use a non-intervention control group
[6,12,14,17,20,21,29,31], six used an attention control group
[7,8,10,16,32,33], four used a wait-list control [9,11,13,22],
three used usual care [25,28,34], and eight were control
groups which could not be definitively categorized
[15,18,19,23,24,26,27,30]. Prior to randomization, nine stud-
ies matched participants according to either sex [12,20,22],
age and sex [21], age, sex and BMI [16], age and duration
Initial records identified  
(n=721)  
- PubMed (n=106)                     - Sport Discus (n=96) 
- CINAHL (n=20)         - Psych INFO (n=10) 
- Scopus (n=135)         - Cochrane (n=73) 
- Acad. Search Complete (n=4)         - PEDro (n=132)  
- Web of Science (n=100)         - Proquest (n=8) 
-Cross-referencing from retrieved articles (n=37) 
Records after duplicates removed 
(n = 500) 
Initial records screened based on title and 
abstract  
(n = 500) 
Records excluded (n = 416), with 
reasons* 
-Abstract (n=24) 
-Duplicate (n=1) 
-Inappropriate intervention (n=102) 
-Inappropriate outcomes (n=7) 
-Inappropriate population (n=16) 
-Inappropriate study design (n=307) 
-Off topic (n=30) 
Full-text articles assessed 
for eligibility  
(n = 84) 
Records excluded (n = 54), with 
reasons* 
-Duplicate (n=1) 
-Inappropriate comparison group 
(n=1) 
-Inappropriate intervention (n=16) 
-Inappropriate outcomes (n=22) 
-Inappropriate population (n=18) 
-Inappropriate study design (n=60) 
Articles scheduled for inclusion in meta-
analysis  
(n = 30)  
Id
en
ti
fi
ca
ti
o
n
 
S
cr
ee
n
in
g
 
E
lig
ib
ili
ty
 
In
cl
u
d
ed
 
Articles included in meta-analysis  
(n = 29)
Records excluded (n = 1), with 
reasons 
-Met criteria but could not retrieve 
data (n=1) 
Figure 1 Flow diagram for the selection of studies. *, number of reasons exceeds the number of studies because some studies were
excluded for more than one reason.
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of symptoms [18], disease status [8], diagnosis of
rheumatoid arthritis or osteoarthritis [19], or score on
the Fibromyalgia Impact Questionnaire [24]. None of
the studies used a crossover design. For data analysis,
19 studies reported using the per-protocol approach
only [6-10,13-22,27-30], five used the intention-to-treat ap-
proach [11,23,25,32,33] and four used both [12,24,26,34].
One other study essentially used an intention-to-treat ap-
proach because they reported no dropouts [31]. Sample size
justification was provided by 14 (48.3%) of the studies
[8,10,11,16,20-22,24-26,28,30,32,33] while 23 (79.3%) re-
ported receiving some type of funding to conduct their in-
vestigation [7-12,14,16-24,26,29-34]. Only seven studies
(24.1%) provided IPD [7,9,11,20,26,27,31]. Dropout data,
available for 32 (91.4%) of the exercise groups ranged from
0% to 50% (x ± SD = 16.2% ± 12.2%, Mdn = 15.3%) while
control group dropouts ranged from 0% to 46% (x ± SD =
14.1% ± 13.3%, Mdn = 12.5%) for the 25 (86.2%) groups in
which data were available. Reasons for participants drop-
ping out or for the investigative team to drop participants
from their study included the following: (1) personal rea-
sons, for example, family or job issues, moved, (2) travel is-
sues, (3) schedule conflicts, (4) health issues, (5) time,
(6) not attending the requisite number of exercise sessions,
(7) lost to follow-up, (8) began taking medications not
allowed during the intervention, (9) pain when exercising,
(10) began other exercise, (11) identification of a co-
morbidity during the intervention, (12) unhappy or unwill-
ing to accept group assignment, (13) exercise too time
consuming or boring, (14) increased pain, (15) not enough
room or privacy to perform exercises, (16) drug intoler-
ance, (17) incomplete assessments, (18) lost contact with
participant, (19) initiated additional treatments and (20)
changed medications.
Participant characteristics
A description of the participant characteristics is shown
in Tables 1 and 2. The majority of participants were
women; fourteen studies were limited to women
[6,9,13-15,18,24-31] while fifteen included both men
and women [7,8,10-12,16,17,19-23,32-34]. No study was
limited to men. With respect to race/ethnicity and as re-
ported by the original study authors, the majority of partici-
pants were non-Hispanic Whites for the fifteen studies in
which data were reported [6,8,10,15,16,19,20,22-26,31-33].
Twelve of the fifteen studies included multiple races/ethnic-
ities [8,10,15,16,19,20,22-24,26,32,33]. The other three stud-
ies were limited to non-Hispanic Whites [31] or other
Hispanics [6,25]. Groups represented in the studies in-
cluded Whites, African-Americans, Hispanics, Native-
Americans and Aboriginals. Two studies reported that
some of the participants smoked cigarettes [8,26] while one
reported that some participants consumed alcohol [8]. An-
other two studies reported that exercise participants in-
creased their exercise outside the actual intervention
[10,25]. With respect to cardiovascular disease risk factors,
one study was limited to overweight and obese participants
[25] while twelve others included some participants who
were overweight or obese [6,10,11,14,16,23,24,29-33]. Two
studies reported that none of the exercise or control group
participants had type 1 or type 2 diabetes [12,27], while one
reported that none of the exercise group participants had
type 2 diabetes [32]. Two studies reported that none of the
participants were hypertensive [12,16] while six included
some who were hypertensive [6,9,19,23,32,33].
For type of AORC, 20 of 29 studies (69.0%) were limited
to participants with fibromyalgia [6,7,9,10,12-16,18,24-31,
33,34], five with osteoarthritis [11,21-23,32], and two with
rheumatoid arthritis [17,20]. One study included partici-
pants with either rheumatoid arthritis or systemic lupus
erythematosus [8] while another included participants
with osteoarthritis or rheumatoid arthritis [19]. For the
14 exercise (40%) and 13 control (44.8%) groups in
which sufficient data were provided, the number of
years in which rheumatic symptoms were present
ranged from 4.7 to 24.0 years in the exercisers (x ± SD =
12.2 ± 5.2, Mdn = 10.7) and 5.1 to 19.4 years in the con-
trols (x ± SD = 11.7 ± 4.2, Mdn = 10.0). With respect to
years since diagnosis, exercise groups ranged from 2.8
to 9.8 years (x ± SD = 5.5 ± 2.5, Mdn = 5.5) for the ten
Table 2 Initial physical characteristics of participants
Exercise Control
Variable Groups (Number) x ± SD Mdn Range Groups (Number) x ± SD Mdn Range
Age (yrs) 33 52.4 ± 9.7 51 35 - 71 28 52.2 ± 9.6 51 36 – 70
Height (cm) 7 160.3 ± 2.9 161 157 - 165 6 160.9 ± 2.0 161 158 – 164
Body weight (kg) 9 70.1 ± 4.9 69 63 - 77 8 71.4 ± 4.0 72 64 – 76
BMI (kg.m2) 15 28.8 ± 2.5 29 24 - 34 13 28.6 ± 2.9 29 25 – 32
Body fat (%) 3 34.9 ± 0.8 35 34 – 35 3 35.1 ± 2.9 36 32 – 38
Symptom duration (yrs) 14 12.2 ± 5.2 11 5 – 24 13 11.7 ± 4.2 10 5 – 19
Diagnosis (yrs) 10 5.5 ± 2.5 5 3 - 10 8 6.2 ± 2.8 6 3 - 11
Groups, number of groups in which data were available. BMI, body mass index; Mdn, median; x  SD, mean ± standard deviation; yrs, years.
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(28.6%) groups in which data were available while the con-
trol groups ranged from 2.5 to 10.5 years (x ± SD = 6.2 ±
2.8, Mdn = 6.3) for the eight (27.6%) groups in which data
were provided.
Exercise intervention characteristics
A description of the exercise interventions for each in-
cluded study is shown in Table 1. As can be seen, the ex-
ercise interventions varied considerably. Length of
training ranged from 4 to 78 weeks (x ± SD = 19 ± 16,
Mdn = 16), frequency (34 groups reporting) from 1 to 9
times per week (x ± SD = 4 ± 2, Mdn = 3) and duration
(31 groups reporting) from 12 to 83 minutes per session
(x ± SD = 34 ± 17, Mdn = 30). For the eighteen groups
(51.4%) in which data were provided, intensity of train-
ing was classified as low for three groups, moderate for
eleven and high for four. Fifteen of the groups focused
on aerobic exercise, five on strength training and eleven
on both. Another four groups participated in meditative
movement therapies that included either tai chi (three
groups) or qigong (one group). Meditative movement
therapies were considered as including both aerobic and
strength training components. With respect to supervi-
sion, eighteen groups participated in supervised exercise,
seven in unsupervised exercise and ten in both. The set-
ting in which the groups exercised mirrored supervision,
with eighteen taking place in a facility-based environ-
ment, seven in a home-based environment, and ten in
both. For the 20 groups (57.1%) in which data were avail-
able, compliance, defined as the percentage of exercise
sessions attended, ranged from 38% to 97% (x ± SD =
74 ± 13, Mdn = 75). Total minutes per week of exercise
for the 30 groups (85.7%) in which data could be calcu-
lated, ranged from 30 to 360 (x ± SD = 108 ± 67, Mdn =
90). When adjusted for compliance (20 groups or 57.1%
of all groups) total minutes per week ranged from 25 to
277 ( x ± SD = 72 ± 60, Mdn = 57). Total minutes of
training over the entire length of the interventions (30
groups) ranged from 360 to 9,360 ( x ± SD = 2,080 ±
2,186, Mdn = 1,404). When adjusted for compliance (20
groups) total minutes ranged from 331 to 5,887 (x ±
SD = 1,532 ± 1,609, Mdn = 839).
Risk of bias assessment
Risk of bias results are shown in Figure 2 while results for
each item from each study are shown in Additional file 3.
Twenty-eight of twenty-nine studies [6-25,27-34] were
considered to be at low risk with respect to sequence gen-
eration while one was considered to be at high risk [26].
Allocation concealment was poorly reported; seven studies
were considered to be at low risk [15,21,24,25,29,32,33],
one at high risk [26] and the remaining twenty-one at un-
clear risk [6-14,16-20,22,23,27,28,30,31,34]. Since it is im-
possible to blind participants in exercise intervention
studies, all included trials were considered to be at a high
risk of bias for the blinding of participants and personnel
category [6-34]. Blinding of outcome assessment was also
poorly reported, with ten studies considered being at low
risk [6,11,12,15,17,20,24,25,29,30], one at high risk [21],
and eighteen at unclear risk [7-10,13,14,16,18,19,22,23,
26-28,31-34]. For incomplete data, that is, attrition bias,
nineteen studies were considered to be at low risk for bias
[6,7,10-13,15-18,22,23,25,26,29,31-34], two at high risk
[20,30] and eight at unclear risk [8,9,14,19,21,24,27,28].
For selective outcome reporting, twenty-five studies were
considered to be at an unclear risk [6-10,12-23,25-31,34]
while four were considered low risk [11,24,32,33]. With re-
gard to participants not exercising regularly prior to
enrollment, thirteen studies were considered to be at
low risk [7,9-11,16,19,20,22,23,26,28-30], one at high risk
[8], and the remaining fifteen at unclear risk
[6,12-15,17,18,21,24,25,27,31-34].
Primary outcome
Depressive symptoms
Overall, there was a statistically significant reduction in
depressive symptoms as well as a statistically significant
and moderate amount of heterogeneity (Table 3 and
Figure 3). In addition, 95% PIs were non-significant. Sta-
tistically significant small-study effects were observed as
indicated by funnel plot asymmetry (Figure 4) as well as
overlapping 95% CI based on Egger’s regression inter-
cept test (β0, −2.4, 95% CI, −3.7 to −1.1) [62]. Reductions
in depressive symptoms remained statistically significant
when data were collapsed so that only one g represented
each study (x , −0.48, 95% CI, −0.67 to −0.30; Q = 164.4,
P <0.001; I2 = 83.0%). When four outliers were deleted
from the model [16,20,27,31], results remained statisti-
cally significant (x , −0.44, 95% CI, −0.58 to −0.31; Q =
73.8, P <0.001; I2 = 59.4%). With each group deleted
from the model once, results remained statistically sig-
nificant across all deletions (Figure 5). The difference be-
tween the largest and smallest values with each group
deleted was 0.05 (11.8%). Cumulative meta-analysis,
ranked by year, demonstrated that results have been sta-
tistically significant since the first included study was
published in 1989 (Figure 6) [19]. The NNT was 7 (95%
CI, 6 to 11) with an estimated 3.1 million (95% CI, 2.0 to
3.7) US adults not currently meeting physical activity
guidelines improving their depressive symptoms if they
began and maintained a regular exercise program. Using
Cohen’s U3 Index, the percentile reduction was 16.4%
(95% CI, 10.4% to 21.9%).
Exploratory moderator (categorical) analyses for changes
in depressive symptoms are shown in Additional file 4. As
can be seen, statistically significant within-group reduc-
tions in depressive symptoms were observed for the ma-
jority of analyses. However, between-group differences
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were limited to gender, with women only groups experien-
cing greater reductions in depressive symptoms than
mixed groups (no study was limited to men) and type of
AORC (reductions in depressive symptoms greater in
fibromyalgia versus rheumatoid arthritis participants).
However, as can be seen, the results for those groups com-
prised of those with rheumatoid arthritis, osteoarthritis or
rheumatoid arthritis and rheumatoid arthritis or systemic
lupus erythematosus, were limited to three, two and one
results, respectively.
Exploratory meta-regression analyses for changes in de-
pressive symptoms and selected continuous covariates are
shown in Additional file 5. As can be seen greater reduc-
tions in depressive symptoms were associated with in-
creases in BMI (R2 = 0.90), greater reductions in pain (R2 =
0.21), improvements in quality-of-life (R2 = 0.46) and de-
creases in static balance (R2 = 0.81). However, the finding
for static balance was limited to three effect sizes.
Secondary outcomes
Changes in secondary outcomes are shown in Table 3.
As can be seen, there were no statistically significant
changes in body weight, BMI in kg.m2, percent body fat
or static balance. In contrast, a statistically significant
improvement was observed for physical function. Het-
erogeneity was considered to be very low and non-
significant. In addition, PI were statistically significant.
Changes were equivalent to a percentile improvement of
21.9%. However, statistically significant small-study ef-
fects were observed (95% CI, 0.16 to 2.72). With each
Table 3 Changes in primary and secondary outcomes
Variable Studies (Number) ES (Number) Participants
(Number)
x (95% CI) Q(P) I2 (%) 95% PI
Primary
- Depressive symptoms (g) 29 35 2449 −0.42 (−0.58, −0.26)* 126.9 (<0.001)** 73.2 −1.23, 0.38
Secondary
- Body weight (kg) 3 3 226 −0.75 (−3.25, 1.74) 3.1 (0.21) 35.2 –
- BMI (kg.m2) 5 5 266 0.08 (−0.19, 0.36) 3.0 (0.55) 0 –
- Body fat (%) 3 3 121 −0.05 (−0.72, 0.62) 0.9 (0.65) 0 –
- Physical function (g) 21 26 1513 0.58 (0.46, 0.70)* 33.0 (0.13) 24.3 0.26, 0.90*
- Pain (g) 25 30 1971 −0.57 (−0.76, −0.38)* 119.6 (<0.001)** 75.7 −1.51, 0.36
- Quality-of-life (g) 18 21 1276 0.73 (0.53, 0.92)* 54.0 (<0.001)** 62.9 −0.03, 1.48
- Anxiety (g) 13 16 976 −0.63 (−0.86, −0.40)* 47.8 (<0.001)** 68.6 −1.49, 0.23
- VO2max (ml
.kg.-1 min−1) 7 10 590 1.73 (0.87, 2.59)* 40. 9 (<0.001)** 78.0 −1.21, 4.67
- Upper body strength (g) 6 9 530 0.51 (0.31, 0.71)* 11.8 (0.16) 32.3 0.04, 0.98*
- Lower body strength (g) 9 10 584 0.83 (0.49, 1.12)* 32.1 (<0.001)** 72.0 −0.28, 1.95
- Balance (g) 3 3 147 0.49 (−0.21, 1.19) 8.1 (0.02) 75.5 –
Boldfaced items indicate statistical significance. *statistically significant, non-overlapping 95% confidence intervals; **statistically significant (P ≤0.10). BMI, body
mass index; ES, effect size; g, Hedges standardized mean difference, adjusted for small-sample bias; I2 (%), I-squared; Q(P), Cochran’s Q statistic and alpha value for
Q; VO2max, maximum oxygen consumption; x (95% CI), mean and 95% confidence interval; 95% PI, 95% prediction intervals; –, insufficient data to calculate.
Figure 2 Risk of bias. Pooled risk of bias results using the Cochrane Risk of Bias Assessment Instrument.
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study deleted from the model once, improvements
remained statistically significant, ranging from 0.55 to
0.60. Results were similar when data were collapsed so
that only one result represented each study (x, 0.57, 95%
CI, 0.45 to 0.70; Q = 27.8, P = 0.11; I2 = 28.1%). Cumula-
tive meta-analysis showed that improvements in physical
function have been statistically significant since the year
1989, the year that the first included study was con-
ducted [19].
Statistically significant decreases in pain were found
with percentile reductions equivalent to 21.5%. However,
heterogeneity was both statistically significant and large.
In addition, PI were non-significant and small-study ef-
fects were observed (95% CI, −4.76 to −1.17). With each
study deleted from the model once, reductions remained
statistically significant, ranging from −0.52 to −0.60.
With three outliers deleted from the model [14,26,27],
results remained statistically significant (x , −0.52, 95%
CI, −0.67 to −0.36; Q = 66.6, P <0.001; I2 = 61.0%).
Results were similar when data were collapsed so that only
one result represented each study (x , −0.63, 95% CI, −0.83
to −0.44; Q = 98.2, P <0.001; I2 = 75.6%). Cumulative meta-
analysis showed that results have been statistically signifi-
cant since the year 1999.
Statistically significant increases in quality-of-life were
also observed with percentile improvements of 26.6%.
Heterogeneity was considered to be statistically signifi-
cant but moderate. Prediction intervals were non-
significant while statistically significant small-study
effects were observed (95% CI, 1.67 to 4.90). With each
study deleted from the model once, increases remained
statistically significant, ranging from 0.67 to 0.76. With
two outliers deleted from the model [14,28], results
remained statistically significant (x , 0.61, 95% CI, 0.47 to
0.76; Q = 27.0, P = 0.08; I2 = 33.3%). Heterogeneity was
reduced by 29.6%, from moderate to low. Cumulative
meta-analysis showed that improvements in quality-of-
life have been statistically significant since the year 2000.
Figure 3 Forest plot for changes in depressive symptoms. Forest plot for point estimate changes in depressive symptoms. The black squares
represent the mean difference while the left and right extremes of the squares represent the corresponding 95% confidence intervals. The middle
of the black diamond represents the overall mean difference while the left and right extremes of the diamond represent the corresponding 95%
confidence intervals. Combined measures represent those studies in which multiple assessment instruments for depression and/or per-protocol
and intention-to-treat analyses were merged.
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For anxiety, statistically significant decreases were ob-
served along with statistically significant and moderate
heterogeneity. Prediction intervals were not statistically sig-
nificant and significant small-study effects were observed
(95% CI, −6.98 to −2.72). Decreases in anxiety were equiva-
lent to a percentile reduction of 23.5%. With each study de-
leted from the model once, deceases remained statistically
significant, ranging from −0.56 to −0.67. Results were simi-
lar when data were collapsed so that only one result repre-
sented each study (x , −0.64, 95% CI, −0.90 to −0.38; Q =
46.9, P <0.001; I2 = 74.4%). Cumulative meta-analysis
showed that decreases in anxiety have been statistically sig-
nificant since 1989, the year that the first included study
was conducted [19].
Increases in aerobic fitness, as assessed by VO2max in
ml.kg-1.min−1, were statistically significant and equivalent
to a percentile improvement of 24.5%. Heterogeneity
was statistically significant and large. In addition, PI
were non-significant. Small-study effects were not statis-
tically significant (95% CI, −5.49 to 4.33). With each
study deleted from the model once, increases remained sta-
tistically significant, ranging from 1.51 to 2.01 ml.kg-1.
min−1. Results were similar when data were collapsed so
that only one finding represented each study (x , 1.62 ml.
kg-1.min−1, 95% CI, 0.57 to 2.67; Q = 37.9, P <0.001; I2 =
84.2%). Cumulative meta-analysis showed that increases in
VO2max in ml
.kg-1.min−1 have been statistically significant
since the year 2003.
Changes in both upper and lower body strength were
statistically significant. For upper body strength, in-
creases were equivalent to a percentile increase of
19.5%. Heterogeneity was non-significant and low. In
addition, no statistically significant small-study effects
were observed (95% CI, −1.56 to 4.11) and PI were sta-
tistically significant. With each study deleted from the
model once, increases remained statistically significant,
ranging from 0.44 to 0.58. Results were similar when
data were collapsed so that only one result represented
each study (x , 0.50, 95% CI, 0.33 to 0.67; Q = 5.5, P =
0.36; I2 = 9.0%). Cumulative meta-analysis showed that
increases in upper body strength have been statistically
significant since the year 1989, the year that the first in-
cluded study was conducted [19]. For lower body
strength, increases were statistically significant and
equivalent to a percentile improvement of 29.7%. Het-
erogeneity was statistically significant but moderate.
Statistically significant small-study effects were ob-
served (95% CI, 1.36 to 5.82) while PI were non-
significant. With each study deleted from the model
once, increases remained statistically significant, ran-
ging from a g of 0.70 to 0.91. Results were similar when
data were collapsed so that only one result represented
each study ( x , 0.81, 95% CI, 0.46 to 1.16; Q = 28.9,
P <0.001; I2 = 72.3%). Cumulative meta-analysis showed
that increases in lower body strength have been statisti-
cally significant since the year 1999.
Figure 4 Funnel plot for changes in depressive symptoms. Small-study effects are apparently present given the lack of results in the lower
right section of the funnel plot.
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Discussion
Findings
The primary purpose of this study was to use the aggre-
gate data meta-analytic approach to determine the ef-
fects of exercise (aerobic, strength training or both) on
depressive symptoms in adults with AORC: fibromyalgia,
osteoarthritis, rheumatoid arthritis and systemic lupus
erythematosus. The overall findings suggest that exercise
is associated with important reductions in depressive
symptoms among selected adults with AORC. This in-
terpretation is supported by: (1) non-overlapping 95% CI
for overall results, (2) consistency with overall results
when each study was deleted from the model once (in-
fluence analysis), (3) consistency with overall results
when outliers were deleted from the model (outlier ana-
lysis), (4) consistency with overall results when data were
collapsed so that one result represented each study (in-
dependence analysis), (5) significance of results over the
entire time period that included studies were conducted
(cumulative meta-analysis), (6) low NNT and (7) number
of people who could potentially benefit by initiating and
maintaining a regular exercise program. Alternatively,
confidence in the overall findings for depressive symp-
toms may be weakened by one or more of the following
five factors. First, while a random-effects model that in-
corporates heterogeneity into the analysis was used, a
moderate amount of heterogeneity, based on a fixed-
effect model, was observed. This suggests that selected
but unknown factors may be associated with the magni-
tude of change, if any, in depressive symptoms among
adults with AORC. Importantly, heterogeneity in meta-
analysis is not only common [71], but also relevant, as
there is no need to combine studies exactly alike since
their findings, within statistical error, would be the same
[72]. Second, statistically significant small-study effects
were observed. While publication bias is one possible
Figure 5 Influence analysis for changes in depressive symptoms. Influence analysis for point estimate changes in depressive symptoms with
each corresponding study deleted from the model once. The black squares represent the mean difference while the left and right extremes of
the squares represent the corresponding 95% confidence intervals. The middle of the black diamond represents the overall mean difference while the
left and right extremes of the diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest to largest reductions.
Combined measures represent those studies in which multiple assessment instruments for depression and/or per-protocol and intention-to-treat
analyses were merged.
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explanation for this finding, other potential factors may
be at play here. These include: (1) other reporting biases
(selective outcome and/or analysis reporting), (2) poor
methodological quality leading to inflated effects in
smaller studies, (3) true heterogeneity, (4) sampling vari-
ation leading to an association between the intervention
effect and standard error and (5) chance [42]. Third,
overlapping PI were observed. However, PI should not
be confused with CI since PI are based on a random
mean effect while CI are not [60]. Nevertheless, non-
overlapping PI would give one more confidence in any
overall findings observed. Fourth, many of the studies
were at a high or unclear risk of bias for several items
from the Cochrane Risk of Bias Assessment Instrument.
These include: (1) allocation concealment, (2) blinding
of outcome assessors, (3) attrition, including reasons, ac-
cording to each group and (4) physical activity levels of
the participants prior to study enrollment. While all of
the included studies were also considered to be at a high
risk of bias for the blinding of participants and
personnel category, it is probably impossible to blind
participants to group assignment in exercise intervention
studies. Therefore, the best that might be expected is to
blind personnel to group assignment. Fifth, some of the
differences observed for the exploratory moderator and
meta-regression results suggest that selected factors may
affect any overall conclusions drawn. These include, but
are not necessarily limited to: (1) method used to assess
depressive symptoms, (2) type of AORC, (3) exercise de-
livery and (4) observed associations between reductions
in depressive symptoms and BMI, pain, quality of life
and static balance. However, the moderator and meta-
regression results need to be viewed cautiously for at
least three reasons. First, because of missing data for dif-
ferent variables from different studies, a common occur-
rence in meta-analysis, multiple meta-regression analysis
Reference Subgroup Combined Measures? Cumulative statistics Cumulative point estimate (95% CI)
Standard 
M inor et al., 1989                      pool 260.00.248-0.349enoN
830.0691.0725.0-enoNklawMinoretal.,1989
0.157                  0.025-0.497NoneNoneDaltroyetal.,1995
Wigers et al., 1996 None Com bined -0.42 0.142 0.020
Kom at ireddy et al.,1997 -0.418                  0.131     0.017NoneNone
-0.450    0.118     0.014NoneNoneBuckelewetal.,1998
O'Reillyet al., 1999 -0.407    0.094     0.009NoneNone
M annerkorpiet al., 2000 None Com bined -0.40 0.088 0.008
Gowanset al., 2001 None Com bined -0.445 0.086 0.007
Hakkinenet al.,2001 010.0990.0794.0-enoNNone
800.0780.0054.0-enoNenoNPatricketal.,2001
500.0270.0814.0-enoNciboreaPenninxetal.,2002
500.0270.0183.0-enoNstrengthPenninxetal.,2002
Schachteret al., 2003 long bout Com bined -0.367 0.067 0.004
Schachteret al., 2003 short bout Com bined -0.355 0.062 0.004
900.0390.0674.0-enoNenoN3002,.latemilaV
010.0990.0035.0-enoNenoNSencanetal.,2004
Valkeinen et al.,2004 900.0790.0835.0-enoNenoN
800.0190.0915.0-enoNloopFransenetal.,2007
800.0980.0884.0-enoNtaichiFransenetal.,2007
Neubergeret al ., 2007 class Com bined -0.452 0.090 0.008
Neubergeret al ., 2007 home Com bined -0.417 0.092 0.009
Rookset al., 2007 aerobic Com bined -0.409 0.089 0.008
Rookset al., 2007 aerobic & strength Com bined -0.404 0.086 0.007
700.0580.0124.0-enoNenoN7002,.latesuraC-samoT
700.0480.0924.0-enoNenoN8002,.lateileG-nrotnelA
700.0580.0754.0-enoNenoNHaak&Scott,2008
700.0380.0744.0-enoNenoNIdeetal.,2008
800.0090.0804.0-enoNenoNJonesetal.,2008
800.0880.0114.0-enoNenoNTomas-Carusetal.,2008
800.0780.0024.0-enoNenoNEtnieretal.,2009
Wang et al.,2009 700.0680.0134.0-enoNenoN
700.0480.0514.0-enoNenoNFontaineetal.,2010
Wanget al.,2010 700.0280.0324.0-enoNenoN
600.0180.0324.0-enoNenoNSanudoetal.,2011
-0.423 0.081 0.006
-1.00 -0.50 0.00 0.50 1.00
Favors Exercise   Favors Control
Figure 6 Cumulative meta-analysis for changes in depressive symptoms. Cumulative meta-analysis, ordered by year, for point estimate
changes in depressive symptoms. The black squares represent the mean difference while the left and right extremes of the squares represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with all studies preceding it. The middle of the black
diamond represents the overall mean difference while the left and right extremes of the diamond represent the corresponding 95% confidence
intervals. Combined measures represent those studies in which multiple assessment instruments for depression and/or per-protocol and
intention-to-treat analyses were merged.
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was not feasible. Thus, the inability to control for rele-
vant variables may have resulted in spurious findings for
the separate analyses conducted. Second, the small sam-
ple sizes for many of the categorical analyses as well as
some of the meta-regression analyses, for example, static
balance, may have yielded spurious results. Third, stud-
ies are not randomly assigned to covariates in meta-
analysis. Thus, they are considered to be observational
in nature. Consequently, the results of moderator and
meta-regression analyses conducted in any meta-analysis
does not support causal inferences and should be viewed
as nothing more than exploratory [66]. Large, well-
designed randomized controlled trials would be needed
to address this issue adequately. Given this, future ran-
domized controlled trials may want to address some of
the differences and associations observed in the current
meta-analysis.
The direction of effect for reductions in depressive
symptoms found in the current meta-analysis (SMD,
−0.42, 95% CI, −0.58 to −0.26) are consistent with previ-
ous meta-analytic work by Busch et al. (SMD, −0.61,
95% CI, −0.99 to −0.23) [37], Hauser et al. (SMD, −0.32,
95% CI, −0.53 to −0.12) [38] and Herring et al. (SMD,
0.29, 95% CI, −0.16 to −0.43) [39] in participants with
fibromyalgia. While the overall magnitude of effect var-
ies between all four meta-analyses, the 95% CI for all stud-
ies overlap, suggesting no statistically significant difference
between them. The former notwithstanding, one possible
reason for the differences in the overall magnitude of ef-
fect may have to do with the fact that the exact same stud-
ies were not included in any of these meta-analyses.
The overall magnitude of reduction for depressive
symptoms observed in the current study (g = −0.42) is
approximately 38.1% greater than that reported in a previ-
ous meta-analysis of pharmacologic interventions limited
to participants with fibromyalgia [73]. Hauser et al. exam-
ined the effects of tricyclic and tetracyclic antidepressants,
selective serotonin reuptake inhibitors, serotonin and nor-
adrenaline reuptake inhibitors and monoamine oxidase in-
hibitors on depressed mood in 18 studies representing
1,427 participants [73]. Overall, a statistically significant
decrease in depressed mood was observed, (standardized
mean difference reduction, −0.26; (95% CI, −0.39 to −0.12)
[73]. However, as opposed to the current meta-analysis,
no statistical heterogeneity was observed (I2 = 0%) [73]. In
addition, the confidence intervals between the current
meta-analysis and the Hauser et al. [73] meta-analysis are
overlapping.
In addition to statistically significant reductions in de-
pressive symptoms, improvements were also observed
for physical function, pain, quality-of-life, anxiety,
VO2max in ml
.kg-1.min−1, and upper and lower body
strength. As opposed to pharmacologic interventions
that generally target one outcome, these findings provide
evidence to support the use of exercise for improving
multiple outcomes. This notwithstanding, the findings
for these secondary outcomes need to be interpreted
with caution given that they were only included if de-
pressive symptoms was included as an outcome. Conse-
quently, the data from which these results were derived
may represent a biased sample.
Implications for research
The results of the current systematic review with meta-
analysis have at least seven implications for the reporting
and conduct of future randomized controlled trials. First,
based on the Cochrane Risk of Bias Assessment Instru-
ment [49], it is recommended that future randomized
controlled trials on the effects of exercise in adults with
AORC improve their reporting with respect to several
potential sources of bias. These include; (1) allocation con-
cealment, (2) blinding of outcome assessors, (3) attrition,
including reasons, according to each group and (4) the
physical activity levels of the participants prior to study
enrollment. While all of the included studies were also
considered to be at a high risk of bias for the blinding of
participants and personnel category, it is probably impos-
sible to blind participants to group assignment in exercise
intervention studies. Therefore, the best that might be ex-
pected is to blind personnel to group assignment.
Second, only four studies used both the per-protocol
and intention-to-treat approach in the analysis of their
data [12,24,26,34]. Given this, it is suggested that future
studies include both in order to gain a better under-
standing regarding the efficacy and effectiveness of exer-
cise for improving depressive symptoms in adults with
AORC [74].
Third, very little data were available for adverse events
as well as the cost-effectiveness of the interventions
employed. Since these are important factors to consider
when making decisions regarding the choice of one
intervention over another, it is suggested that future
studies collect and report this information.
Fourth, complete information should be collected and
reported on the exercise intervention(s) employed. For
example, in the current meta-analysis, data on the inten-
sity of exercise as well as compliance with the exercise
intervention were underreported. More specifically, fu-
ture studies should report complete information on the
length, frequency, intensity and duration of exercise,
mode(s) used, and compliance with the exercise proto-
col. Also, information on the setting in which exercise
takes place as well as supervision status should be re-
ported. Because of the potential for physical activity
compensation to occur [75], data should also be col-
lected and reported on total physical activity for all
groups included in the study. The rationale for this sug-
gestion is based on the possibility that physical activity
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levels beyond any intervention(s) may increase or de-
crease in the intervention and/or control groups. For ex-
ample, two of the included studies reported that exercise
participants increased their physical activity beyond the
exercise intervention [10,25]. Increases or decreases such
as these may negatively impact the results of one or
more outcomes and may be especially problematic when
trying to address the issue of dose–response.
Fifth, since the dose–response effects of exercise on
depressive symptoms in adults with AORC are not
known, it is suggested that future randomized controlled
trials address this issue. The determination of such is
critical for the development of optimal exercise pro-
grams for improving depressive symptoms in adults with
AORC. Along those lines and as previously mentioned,
it would appear plausible to suggest that an examination
of some of the differences and associations observed in
the current meta-analysis would be appropriate. For ex-
ample, if feasible, a multi-arm, randomized controlled
exercise intervention trial that includes participants with
different types of AORC may be appropriate.
Sixth, while fourteen of the included studies were lim-
ited to women [6,9,13-15,18,24-31] and fifteen were
mixed [7,8,10-12,16,17,19-23,32-34], none were limited
to men. Given that the age-adjusted prevalence of
doctor-diagnosed arthritis in the US has been reported
to be 18.6% in men and that the biology between men
and women differs, future studies limited to men or that
include both men and women with results partitioned
according to sex, seem appropriate.
Seventh, since no study was limited to participants
with systemic lupus erythematosus and only two were
limited to adults with rheumatoid arthritis [17,20], fu-
ture exercise intervention studies may want to focus
on these populations. Such a focus may allow one to
draw more definitive conclusions regarding the effects
of exercise on depressive symptoms in these specific
populations.
In addition to the reporting and conduct of future ran-
domized controlled trials, the current meta-analysis pro-
vides at least three implications for future systematic
reviews with meta-analysis. First, the a priori plan of the
current study was to conduct a one-step IPD meta-
analysis [51]. Nevertheless, because of: (1) the ability to
obtain IPD from only 24.1% of eligible studies, (2) the
inability to resolve discrepancies between the IPD pro-
vided and data reported in the published studies, for ex-
ample, final sample sizes, and (3) the potential loss of
power with fewer included studies, a post hoc decision
was made to conduct an aggregate data meta-analysis,
an approach similar to conducting a two-step meta-
analysis with IPD [51]. While IPD meta-analysis is con-
sidered by some to be the gold standard [51,76], primar-
ily because of the potential to conduct covariate analyses
at the participant level, this has to be considered with re-
spect to obtaining IPD from all eligible studies. In
addition, causal inferences based on covariate analyses,
whether conducted using IPD or aggregate data, cannot
be made given that experiments are never randomly
assigned to covariates [66,77]. Furthermore, the time
and costs associated with conducting an IPD meta-
analysis have been shown to be substantially greater than
conducting an aggregate data meta-analysis. For ex-
ample, in 1997, Steinberg et al. estimated the cost for 12
ovarian cancer studies to be $259,300 for conducting an
IPD meta-analysis versus $48,665 for an aggregate data
meta-analysis [78]. However, this 5.3 times greater cost
has been suggested by others to be 8 times greater since
the research team continued to work on the project after
funding ended [77]. Importantly, the use of IPD is not
always well established. To illustrate, when examining
overall effects, the primary purpose of meta-analysis
[72], studies claiming the superiority of IPD have been
based on comparisons of a different number of studies
between IPD and aggregate data [79,80]. However, when
an indistinguishable or a nearly indistinguishable num-
ber of studies were included, the overall results were
found to be analogous [78,81,82]. Finally, despite the in-
creased use of IPD in recent years [83], the aggregate
data approach is still the most frequently used when
conducting a meta-analysis. Given this, future investiga-
tors planning a meta-analysis should think very carefully
about the feasibility and potential gain derived from con-
ducting an IPD versus aggregate data meta-analysis.
Second, given that the secondary outcomes included
in the current meta-analysis may represent a biased sam-
ple, future meta-analytic work that includes one or more
of these as a primary outcome might be important. For
example, recent research has shown that the prevalence
of anxiety among US adults was approximately twice as
high as depression (30.5% versus 17.5%), with US popu-
lation estimates of 11.5 million for anxiety and 6.6 mil-
lion for depression [4]. However, a previous systematic
review by the first two authors did not identify any pre-
vious systematic reviews with meta-analysis that met
their inclusion criteria with respect to the effects of exer-
cise on anxiety in adults with AORC (unpublished re-
sults). Given the reductions observed for anxiety in the
current meta-analysis, it is suggested that a full system-
atic review with meta-analysis that includes anxiety as a
primary outcome is warranted.
Third, the ultimate goal in the treatment of any condi-
tion is the identification of what treatments work best,
that is, comparative effectiveness research. However, it is
highly unlikely that any large multi-arm randomized
controlled trial will ever be conducted that includes all
possible pharmacologic and non-pharmacologic inter-
ventions that address the effects of depressive symptoms
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in adults with AORC. Alternatively, one cost-effective
approach is the use of network meta-analysis, an in-
creasingly popular method that allows one to incorpor-
ate both direct and indirect evidence in decisions about
which treatment works best [84,85]. To the best of the
investigative team’s knowledge, no such study exists with
respect to depressive symptoms in adults with AORC.
Implications for practice
The results of the current meta-analysis in adults with
AORC have relevant implications for practice. Overall, it
appears that exercise may improve depressive symptoms
as well as a number of other outcomes (physical function,
pain, quality-of-life, anxiety, VO2max in ml
.kg-1.min−1 and
strength) in selected adults with AORC. Given this and
despite the fact that no dose–response effects of exercise
on depressive symptoms were identified and there was a
lack of reporting for adverse events and cost-effectiveness,
it would appear plausible to suggest that exercise might be
a valuable addition to the treatment of adults with
AORC. While such programs may need to be individu-
ally tailored to each person’s specific condition, follow-
ing the general guidelines recommended by the US
Centers for Disease Control and Prevention in adults
with arthritis may be an appropriate starting point, es-
pecially if viewed from a community-based, public
health perspective [86]. This includes 150 minutes per
week of moderate-intensity aerobic activity, for ex-
ample, brisk walking, 75 minutes per week of vigorous-
intensity aerobic activity, for example, water aerobics,
or some equivalent combination of both moderate and
vigorous-intensity activity [86]. In addition, muscle
strengthening exercises using equipment such as re-
sistance bands is recommended on two or more days
per week as well as balance exercises, for example,
standing on one foot, at least three days per week [86].
When initiating an exercise program, it is suggested
that participants with AORC: (1) start with activity
performed over a short duration and at a low intensity,
(2) modify one’s activity when arthritis symptoms in-
crease, (3) participate in activities that do not place un-
due stress on the joints, for example, swimming versus
running, (4) exercise in environments that are safe,
and (5) seek guidance from a healthcare professional
or certified exercise specialist [86].
Strengths and limitations of current study
Strengths
There are least four potential strengths of the current
meta-analysis. First, to the best of the investigative
team’s knowledge, this is the first meta-analysis to exam-
ine the effects of exercise on depressive symptoms as a
primary outcome in adults with AORC beyond those
with fibromyalgia [36]. Thus, this adds important
information as well as direction for future research and
practical application regarding the effects of exercise on
depressive symptoms in adults with AORC. Second, the
inclusion of the NNT provides practical information to
aid decision-makers in deciding what treatments to rec-
ommend or prioritize over others when attempting to
reduce depressive symptoms in adults with AORC.
Third, gross estimates of the number of US adults with
AORC who might reduce their depressive symptoms by
participating in a regular exercise program can help aid
decision-makers and others in allocating the resources
necessary for increasing exercise in this population.
Fourth, the calculation and inclusion of PI can aid re-
searchers when planning future randomized controlled
trials on this topic.
Limitations
The results of the current meta-analysis should be
viewed with respect to the following five potential limi-
tations. First, a large number of statistical tests were
conducted but no adjustments were made for multiple
testing because of the concern about missing possibly
important findings that could be pursued in future ran-
domized controlled trials [87]. While this may be viewed
by some as a ‘fishing expedition’, the investigative team
felt that these pre-planned analyses were important for
providing investigators with potential direction for fu-
ture randomized controlled trials. Nevertheless, some
statistically significant results observed may have been
chance findings. Second, the sample sizes for many of
the analyses were small and, thus, probably underpow-
ered to find a true effect or difference. In addition, the
generalizability of results based on these small sample
sizes is questionable. Third, given the different assess-
ment instruments used as well as a lack of information
provided on the severity of depressive symptoms upon
study entry, the investigative team was unable to assess
accurately whether greater decreases might be achieved
by those with greater depressive symptoms at baseline.
Fourth, the weaknesses and limitations of the studies in-
cluded in any meta-analysis are inherited by the meta-
analysis itself and, thus, may have a deleterious effect on
any findings and conclusions drawn. Fifth, like any
meta-analysis, the results of the current investigation
may be prone to ecological fallacy and/or Simpson’s
Paradox [77].
Conclusions
Exercise is associated with decreases in depressive symp-
toms among selected adults with AORC. A need exists
for additional, well-designed and reported randomized
controlled trials on this topic.
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